Evolution of systemic treatment for advanced hepatocellular carcinoma-Reference-Cited by-同舟云学术

Evolution of systemic treatment for advanced hepatocellular carcinoma

Published:2021-07-02 Issue:8 Volume:37 Page:643-653
ISSN:1607-551X
Container-title:The Kaohsiung Journal of Medical Sciences
language:en
Short-container-title:The Kaohsiung Journal of Medical Sciences

Author:

Wu Tsung‐Che¹^ORCID,Shen Ying‐Chun¹²³,Cheng Ann‐Lii¹²³

Affiliation:

1. Department of Oncology National Taiwan University Hospital Taipei Taiwan

2. Department of Medical Oncology National Taiwan University Cancer Center Taipei Taiwan

3. Graduate Institute of Oncology School of Medicine, National Taiwan University Taipei Taiwan

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/kjm2.12401

Reference80 articles.

1. Doxorubicin versus no antitumor therapy in inoperable hepatocellular carcinoma. A prospective randomized trial

2. Potential roles for preclinical pharmacology in phase I clinical trials;Collins JM;Cancer Treat Rep,1986

3. Phase II study of gemcitabine in patients with advanced hepatocellular carcinoma

4. Multicentre phase II trial of capecitabine plus oxaliplatin (XELOX) in patients with advanced hepatocellular carcinoma: FFCD 03-03 trial

5. Complete pathological remission is possible with systemic combination chemotherapy for inoperable hepatocellular carcinoma;Leung TW;Clin Cancer Res,1999

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research progress of small molecule fluorescent probes for liver cancer related enzymes;Dyes and Pigments;2023-11

2. Mathematical Modeling Reveals Mechanisms of Cancer-Immune Interactions Underlying Hepatocellular Carcinoma Development;Mathematics;2023-10-12

3. The New Era of Systemic Treatment for Hepatocellular Carcinoma: From the First Line to the Optimal Sequence;Current Oncology;2023-09-26

4. Serum resistin and the risk for hepatocellular carcinoma in diabetic patients;World Journal of Gastroenterology;2023-07-21

5. Tanshinone IIA and hepatocellular carcinoma: A potential therapeutic drug;Frontiers in Oncology;2023-01-31